Viewing Study NCT02685020


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-02-22 @ 9:29 AM
Study NCT ID: NCT02685020
Status: COMPLETED
Last Update Posted: 2025-02-03
First Post: 2016-02-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability and Immunogenicity Study of Different Vaccine Schedules With Ad26.Mos.HIV and Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults
Sponsor: Janssen Vaccines & Prevention B.V.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Healthy View
None Human Immunodeficiency Virus View
None adenovirus serotype 26 View
None Ad26.Mos.HIV View
None Vaccine View
None Placebo View
None Glycoprotein View
None IPCAVD010 View